GlassScriptPhysician profile
Michelle O'Shea
NPI 1023040771
$467.54
in general payments reported to CMS, 2019-2025
9 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $49.26 · 2022: $52.04 · 2023: $66.68 · 2024: $176 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $366.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endomagnetics LTD | $153.45 | 2024 | Magtrace, Magseed |
| Myriad Genetic Laboratories, INC. | $94.53 | 2021-2023 | Myrisk |
| Axogen | $54.95 | 2025 | |
| Stryker Corporation | $42.75 | 2023-2025 | Spy-Phi System, Molli |
| Merck Sharp & Dohme LLC | $33.90 | 2025 | Lynparza, Keytruda |
| Aroa Biosurgery Incorporated | $25.79 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $24.27 | 2021 | |
| Leica Microsystems INC. | $22.18 | 2024 | Mammotome Revolve |
| Coopersurgical, INC. | $15.72 | 2025 | Onetrac Lx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle O'Shea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.